Alcon launches solution for personalized vision correction surgery in Korea

Alcon Korea said it launched its personalized vision correction surgery solution, PersonalEYES, also known as Wavelight Plus globally, in Korea.

The company unveiled the technology at a press conference held at the Plaza Hotel in Seoul on Thursday, highlighting its commitment to advancing personalized vision correction.

The innovative PersonalEYES solution is designed to enhance the quality of vision correction surgery by integrating advanced diagnostic tools and treatment customization.

“PersonalEYES represents a groundbreaking personalized vision correction surgery that offers an efficient treatment process and consistent, optimal surgical environments for medical professionals, while delivering superior vision improvement outcomes for patients,” Alcon Korea’s Country Franchise Head Surgical & Country Manager Choi Jun-ho said.

Choi noted the global rise in myopia rates, with nearly 50 percent of the world’s population projected to be affected by 2050. He emphasized that innovations like PersonalEYES can transform vision correction surgery, offering hope for millions seeking tailored solutions.

At the heart of the PersonalEYES solution is the SightMap diagnostic device, which applies ray-tracing technology to perform a comprehensive analysis of the patient's eye.

This technology corrects high-order aberrations that traditional glasses, contact lenses, or standard surgeries cannot address.

The system generates a detailed 3D virtual eye model, incorporating data such as refractive power, corneal curvature, wavefront analysis, and axial length, to deliver a highly personalized treatment plan.

The SightMap device automates refraction testing and aggregates data, eliminating the need for surgeons to manually input nomograms for laser power, intensity, and positioning. This innovation reduces procedural time and minimizes the potential for human error, enabling surgeons to focus more on patient care.

“PersonalEYES allows for precise 3D modeling of each patient’s eye using tens of thousands of data points, ensuring accurate and efficient surgeries,” B&VIIT Eye Center Doctor Ryu Ik-hee said. “This not only eliminates errors caused by complex calculations but also aligns predicted surgical outcomes with actual results, setting a new benchmark in personalized vision correction.”

Ryu stressed that PersonalEyes is not just a simple combination of previously independent diagnostic equipment, but a system fundamentally designed to help patients achieve optimal visual outcomes.

"It offers a way to correct not only simple vision problems but also symptoms that were previously difficult to address, such as glare and refractive errors,” Ryu said. "This surgical method can be applied to anyone seeking vision correction, but it is particularly recommended for those with higher-level vision-related needs.”

It is suitable for individuals in professions that require extensive use of their eyes, those who work frequently at night, or those with eye conditions that hinder success with conventional surgeries., Ryu added.

During the conference, First Samsung Eye Clinic Director Choi Sung-ho explained that clinical trials of PersonalEYES have shown remarkable results.

In a study involving 200 LASIK patients, three months post-surgery, all participants achieved an uncorrected distance visual acuity (UDVA) of at least 1.0 (20/20), with 89 percent reaching 1.25 (20/16).

Notably, 50 percent recorded a visual acuity of 1.6 (20/12.5), and 8 percent attained 2.0 (20/10). Also, 98 percent of eyes showed UDVA within one line of their preoperative corrected distance visual acuity (CDVA), and 94 percent achieved results equal to or better than their preoperative CDVA.

"When treating patients, we often see cases where their vision is clear, but they experience severe glare or light reflection, prompting them to visit the clinic,” Choi said. “Patients prioritize the quality of vision after surgery, and PersonalEYES delivers exceptional outcomes that exceed expectations.”

It also reduces asymmetry and high-order aberration variability, providing patients with enhanced vision quality and high satisfaction, Choi added.